Apyx Medical Balance Sheet Health
Financial Health criteria checks 5/6
Apyx Medical has a total shareholder equity of $26.9M and total debt of $33.2M, which brings its debt-to-equity ratio to 123.3%. Its total assets and total liabilities are $79.2M and $52.3M respectively.
Key information
123.3%
Debt to equity ratio
US$33.19m
Debt
Interest coverage ratio | n/a |
Cash | US$43.65m |
Equity | US$26.92m |
Total liabilities | US$52.32m |
Total assets | US$79.24m |
Recent financial health updates
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth
May 26We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth
Jan 08Recent updates
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin
Jul 18Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth
May 26Are Investors Undervaluing Apyx Medical Corporation (NASDAQ:APYX) By 42%?
Mar 15We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth
Jan 08We Think Apyx Medical (NASDAQ:APYX) Can Easily Afford To Drive Business Growth
Sep 28Most Shareholders Will Probably Find That The CEO Compensation For Apyx Medical Corporation (NASDAQ:APYX) Is Reasonable
Jul 31Financial Position Analysis
Short Term Liabilities: APYX's short term assets ($70.4M) exceed its short term liabilities ($12.7M).
Long Term Liabilities: APYX's short term assets ($70.4M) exceed its long term liabilities ($39.6M).
Debt to Equity History and Analysis
Debt Level: APYX has more cash than its total debt.
Reducing Debt: APYX's debt to equity ratio has increased from 0.2% to 123.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APYX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: APYX has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 0.5% each year.